Dactolisib outperforms Rapamycin in potentiating apoptosis induced by XPO1, Bcl-2 and Mcl-1 blockade in preclinical glioblastoma models.
Zhao K, Meyer L, Braun M, Otte K, Bitter C, Pawlik M, Raifer H, Helmprobst F, Pagenstecher A, Urban H, Burger MC, Ronellenfitsch MW, Steinbach JP, Jedelská J, Bagheri S, Yousefi BH, Di Fazio P, Luster M, Mahnken AH, Neubauer A, Burchert A, Nimsky C, Bartsch JW, Rusch T